TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be? September 26, 1986
TCL Archive CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications September 3, 1982
